CI

Cigna Corporation [CI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CI Stock Summary

Top 10 Correlated ETFs

CI


Top 10 Correlated Stocks

CI


In the News

07:21 29 Mar 2024 CI

Cigna (CI) Surpasses Market Returns: Some Facts Worth Knowing

Cigna (CI) reachead $363.34 at the closing of the latest trading day, reflecting a +1.57% change compared to its last close.

10:46 29 Mar 2024 CI

Why Cigna (CI) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

09:56 29 Mar 2024 CI

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

10:31 29 Mar 2024 CI

Brokers Suggest Investing in Cigna Group (CI): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

09:05 29 Mar 2024 CI

S&P 500 Achieves a New Milestone: Top 5 Non-Tech Picks

We have narrowed our search to five non-tech S&P 500 stocks that have provided double-digit returns year to date. These are: CI, RL, PH, ETN, EBAY.

07:20 29 Mar 2024 CI

Cigna (CI) Increases Yet Falls Behind Market: What Investors Need to Know

In the most recent trading session, Cigna (CI) closed at $352.63, indicating a +0.16% shift from the previous trading day.

12:46 29 Mar 2024 CI

CI or HUM: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - HMOs sector might want to consider either Cigna (CI) or Humana (HUM). But which of these two stocks offers value investors a better bang for their buck right now?

05:10 29 Mar 2024 CI

Are These 3 Beaten-Down S&P 500 Members Worth a Look?

The market has enjoyed a fantastic run in 2024, building nicely on last year's gains. Up 8% YTD, the S&P 500's strong performance has been aided significantly by large-cap technology, with others also joining the party.

08:50 29 Mar 2024 CI

5 Low Price-to-Sales Stocks to Fetch Solid Portfolio Gains

The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PAGS, AMG, CI, BBSI and FIHL hold promise.

10:16 29 Mar 2024 CI

Cigna Group (CI) Soars to 52-Week High, Time to Cash Out?

Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CI Financial details

Company Rating
Strong Buy
Market Cap
102.84B
Income
3.8B
Revenue
195.2B
Book val./share
158.03
Cash/share
29.9
Dividend
5.09
Dividend %
1.4%
Employees
70.33K
Optionable
Yes
Shortable
Yes
Earnings
02 May 2024
P/E
27.99
Forward P/E
13.66
PEG
-7.1
P/S
0.54
P/B
2.3
P/C
12.15
P/FCF
10.37
Quick Ratio
0.67
Current Ratio
0.77
Debt / Equity
0.67
LT Debt / Equity
0.61
-
-
EPS (TTM)
12.9
EPS next Y
26.58
EPS next Q
7.69
EPS this Y
-17.51%
EPS next Y
106.03%
EPS next 5Y
213.49%
EPS last 5Y
5.29%
Revenue last 5Y
4.89%
Revenue Q/Q
4.14%
EPS Q/Q
2414.29%
-
-
-
-
SMA20
4.77%
SMA50
15.06%
SMA100
15.7%
Inst Own
69.58%
Inst Trans
0.81%
ROA
3%
ROE
8%
ROC
0.07%
Gross Margin
81%
Oper. Margin
3%
Profit Margin
2%
Payout
38%
Shs Outstand
292.36M
Shs Float
287.05M
-
-
-
-
Target Price
296.86
52W Range
240.5-355.73
52W High
+2.31%
52W Low
+51.33%
RSI
77.61
Rel Volume
0.7
Avg Volume
1.65M
Volume
1.16M
Perf Week
3.07%
Perf Month
7.26%
Perf Quarter
27.28%
Perf Half Y
25.9%
-
-
-
-
Beta
0.558
-
-
Volatility
4.3%, 8.18%
Prev Close
-0.04%
Price
363.19
Change
0.89%

CI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
408.98439.96515.66534.5664.15
Net income per share
13.5823.1715.8919.8417.57
Operating cash flow per share
25.2328.3621.2825.6140.2
Free cash flow per share
22.4425.3617.8621.7834.84
Cash per share
14.7831.5417.7620.2129.76
Book value per share
120.61137.87139.4132.77157.28
Tangible book value per share
-95.19-80.66-96.84-98.69-97.9
Share holders equity per share
120.61137.87139.4132.77157.28
Interest debt per share
103.9894.13103.295.64110.3
Market cap
76.87B75.98B77.61B111.98B88.01B
Enterprise value
109.66B98.72B106.2B137.15B111.66B
P/E ratio
15.068.9814.4516.717.04
Price to sales ratio
0.50.470.450.620.45
POCF ratio
8.17.3410.7912.947.45
PFCF ratio
9.118.2112.8615.218.59
P/B Ratio
1.71.511.652.51.9
PTB ratio
1.71.511.652.51.9
EV to sales
0.710.610.610.760.57
Enterprise value over EBITDA
-1.188.579.4211.0221.62
EV to operating cash flow
11.569.5414.7715.849.45
EV to free cash flow
1310.6717.5918.6310.9
Earnings yield
0.070.110.070.060.06
Free cash flow yield
0.110.120.080.070.12
Debt to equity
0.830.650.710.690.67
Debt to assets
0.240.210.220.220.21
Net debt to EBITDA
-0.351.972.542.024.58
Current ratio
1.011.32.842.670.77
Interest coverage
-57.46.066.917.743.57
Income quality
1.851.221.331.282.29
Dividend Yield
0.010.060.020.010.02
Payout ratio
0.130.580.250.210.28
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.520.510.520.540.51
Capex to operating cash flow
-0.11-0.11-0.16-0.15-0.13
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.29-0.39-0.39-0.44-0.52
Stock based compensation to revenue
0-0.03000.05
Graham number
191.95268.12223.24243.43249.36
ROIC
-0.90.080.080.10.06
Return on tangible assets
0.070.110.070.10.07
Graham Net
-243.79-216.25-250.83-216.87-245.83
Working capital
314M6.71B16.9B18.02B-11.37B
Tangible asset value
-35.79B-29.44B-32.73B-33.35B-28.77B
Net current asset value
-89.02B-76.16B-81.61B-70.19B-64.22B
Invested capital
0.830.650.710.690.67
Average receivables
15.9B16.6B18.74B21.03B22.82B
Average payables
15.31B17.18B12.74B7.22B8.16B
Average inventory
2.74B2.91B3.44B4.25B5.21B
Days sales outstanding
37.5539.5342.0944.3744.28
Days payables outstanding
184.09210.0672.3888.1286.03
Days of inventory on hand
31.5235.3240.4854.1456.78
Receivables turnover
9.729.238.678.238.24
Payables turnover
1.981.745.044.144.24
Inventory turnover
11.5810.339.026.746.43
ROE
0.110.170.110.150.11
Capex per share
-2.79-3-3.41-3.83-5.35

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
153.15157.11165.06166.8174.63
Net income per share
3.914.284.960.143.52
Operating cash flow per share
7.03178.469.615.02
Free cash flow per share
5.8715.627.118.243.77
Cash per share
22.8629.9235.5132.4529.9
Book value per share
150.24150.49154.31155.38158.03
Tangible book value per share
-111.67-112.67-108.65-106.67-98.36
Share holders equity per share
150.24150.49154.31155.38158.03
Interest debt per share
105.19111.26112.38104.66107.11
Market cap
98.96B75.56B82.64B84.12B87.59B
Enterprise value
124.13B100.17B105.79B106.76B111.25B
P/E ratio
21.1614.9114.15512.9321.28
Price to sales ratio
2.161.631.71.721.71
POCF ratio
47.1515.0333.1629.7759.71
PFCF ratio
56.4216.3639.4534.7279.48
P/B Ratio
2.211.71.821.841.89
PTB ratio
2.211.71.821.841.89
EV to sales
2.712.162.182.182.18
Enterprise value over EBITDA
52.6449.7147.6347.66108.11
EV to operating cash flow
59.1419.9242.4537.7875.83
EV to free cash flow
70.7721.6850.544.06100.95
Earnings yield
0.010.020.0200.01
Free cash flow yield
0.020.060.030.030.01
Debt to equity
0.690.730.720.680.67
Debt to assets
0.220.220.220.210.21
Net debt to EBITDA
10.6712.2110.4210.1122.99
Current ratio
2.670.720.730.730.77
Interest coverage
5.013.546.12-6.142.86
Income quality
1.753.851.651.951.43
Dividend Yield
00000
Payout ratio
0.290.290.258.830.35
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.540.530.520.520.51
Capex to operating cash flow
-0.16-0.08-0.16-0.14-0.25
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.47-0.54-0.53-0.53-0.48
Stock based compensation to revenue
0.0100.030.03-0.06
Graham number
115.02120.45131.1922.08111.84
ROIC
0.020.010.0200.08
Return on tangible assets
0.020.020.0200.01
Graham Net
-245.39-254.25-251.97-252.08-246.99
Working capital
18.02B-12.7B-12.63B-12.54B-11.37B
Tangible asset value
-33.35B-33.32B-32B-31.37B-28.77B
Net current asset value
-70.19B-71.35B-69.82B-69.36B-64.22B
Invested capital
0.690.730.720.680.67
Average receivables
22.03B22.48B23.23B23.74B23.84B
Average payables
15.66B7.57B7.72B7.87B8.11B
Average inventory
4.4B4.49B4.36B4.47B5.03B
Days sales outstanding
43.2144.5443.4644.0441.72
Days payables outstanding
21.7373.2380.4277.3682.95
Days of inventory on hand
13.3541.944.9744.5254.75
Receivables turnover
2.082.022.072.042.16
Payables turnover
4.141.231.121.161.08
Inventory turnover
6.742.1522.021.64
ROE
0.030.030.0300.02
Capex per share
-1.16-1.38-1.35-1.37-1.25

CI Frequently Asked Questions

What is Cigna Corporation stock symbol ?

Cigna Corporation is a US stock , located in Bloomfield of Ct and trading under the symbol CI

Is Cigna Corporation buy or a sell ?

32 stock analysts have 32 predictions with a medium analyst target price of $298.84. The lowest prediction is $225 and the highest is $372

What is CI stock prediction ?

With a median analyst target price of $366.5, 4 stock analysts have made 4 forecasts in last 90 days. $354 is the lowest and $372 is the greatest projection.

What is Cigna Corporation stock quote today ?

Cigna Corporation stock price is $363.19 today.

Is Cigna Corporation stock public?

Yes, Cigna Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap